---

Market Overview

---

The global body contouring devices market is projected to surpass USD 12.6 billion by 2027, growing at a CAGR of 13.96% from 2022 to 2027. This growth is primarily driven by the increasing demand for medical aesthetic treatments. The field of medical aesthetics is experiencing rapid expansion due to factors such as the growing aging population and the introduction of advanced procedures, which offer new growth opportunities for the market. Among the various medical aesthetic treatments, micro-needling and skin tightening procedures are witnessing significant growth worldwide.

Body contouring devices are designed to enhance body appearance. These devices enable minimally invasive or non-invasive surgical procedures that improve body shape and skin texture, including skin tightening, resurfacing, and other associated benefits. Such procedures require highly skilled medical professionals. Examples of body contouring procedures performed using these devices include abdominoplasty or liposuction, removal of man breasts, and arm lifts.

Several factors are driving the growth of the body contouring devices market. Firstly, there is a growing demand for minimally invasive or non-invasive procedures, as patients seek treatments with minimal downtime and lower risks. Additionally, improvements in the economic environment and greater accessibility to aesthetic services, along with an expanded base of practitioners, have contributed to market growth. The rising prevalence of obesity worldwide and the increasing desire for a youthful and fit body among individuals have also fueled demand for body contouring procedures. Moreover, reductions in the cost per aesthetic procedure, coupled with the wide acceptance of aesthetic treatments and a heightened focus on body image and appearance, have further propelled market growth. Lastly, the aging demographics of industrialized countries have created a demand for procedures that address the visible signs of aging.

Several companies have made technological advancements in body contouring devices. These advancements include innovations in temperature-controlled fat reduction devices, cellulite treatment devices, non-invasive sclerotherapy treatments, and developments in laser-based techniques. For example, the Accent Prime body contouring device from Alma Lasers (FOSUN PHARMA) utilizes the latest ultrasound and RF technologies to deliver effective and customizable treatments for skin tightening and aesthetic enhancement. This device offers natural and long-lasting results.

---

Market Segmentation

---

The market is segmented based on various factors, including application, gender, age group, end-user, and geography.

Segmentation by Application
Non-Surgical Skin Tightening
Non-Surgical Skin Resurfacing
Liposuction
Cellulite Treatment
Others

Segmentation by Gender
Female
Male

Segmentation by Age Group
Under 34 Years
Between 34 & 50 Years
Above 50 Years

Segmentation by End-User
Hospitals & Skin Clinics
Medical Spa & Beauty Centres
Others

Segmentation by Geography
North America – US, Canada
Europe – Germany, France, UK, Italy, Spain, Russia
APAC – China, Japan, India, South Korea, Australia
Latin America – Brazil, Mexico, Argentina
Middle East & Africa – South Africa, Saudi Arabia, Turkey, UAE

The non-surgical skin tightening segment is the dominant category in the global body contouring devices market, holding the highest market share. It is projected to grow at the fastest rate with a compound annual growth rate (CAGR) of 14.81% during the forecast period. The increasing demand for skin tightening devices can be attributed to factors such as the growing aging population, which results in sagging skin issues, and rising concerns about skin problems. In 2018, the American Society for Dermatologic Surgery (ASDS) reported that approximately 70% of consumers considered cosmetic procedures, with 57% specifically considering non-surgical skin tightening treatments. This segment also experiences continuous technological advancements.

North America has the highest market share in the global skin resurfacing market due to the widespread adoption of technologically advanced devices, the presence of skilled professionals, and higher disposable incomes. On the other hand, the Asia-Pacific (APAC) region is expected to grow at a faster pace during the forecast period due to its growing economy, medical tourism market, and higher disposable incomes.

The increasing obese population has created significant opportunities and demand for liposuction/lipolysis and cellulite treatment devices. According to the American Society for Aesthetic Plastic Surgery (ASAPS), non-surgical fat reduction was the second most in-demand procedure after injectables in 2018. To address the high complications and costs associated with surgical liposuction procedures, many companies are developing and offering minimally invasive lipolysis devices. For example, Bausch Health Companies’ Solta Medical and Alma Lasers now offer next-generation minimally invasive liposuction systems utilizing ultrasound and laser technologies.

The demand for non-surgical skin tightening and fat reduction procedures is primarily driven by females. The most popular cosmetic procedures experiencing the highest growth among females since 2018 include botulinum toxin, hyaluronic acid, and non-surgical fat reduction procedures. In the United States, approximately 92% of cosmetic surgeries were performed on females in contrast to only 8% on males in 2020. This signifies that females dominate the consumer population in the global body contouring devices market.

However, in recent years, body contouring treatments have become increasingly important for men. There is a growing demand among the male population for procedures such as jawline contouring, abdominoplasty, and gynecomastia treatments.

The age group between 35 and 50 dominates the global body contouring devices market. This age group seeks the most cosmetic procedures such as liposuction, abdominal fat reduction, and breast reduction. It is expected to experience the highest CAGR of 14.35% during the forecast period. Conversely, the under 34 age group prefers anti-aging surgical and non-surgical procedures aimed at minimizing wrinkles and rejuvenating the face.

Hospitals and skin clinics are the primary end-users in the body contouring devices market, accounting for the largest market share of 63.31%. These facilities are the main centers for medical aesthetics, offering various procedures including skin tightening, fat reduction, cellulite treatment, etc. Medical professionals such as plastic surgeons and dermatologists provide patients with well-planned treatment options.

Medical spas and beauty centers represent the second largest end-user segment in the body contouring devices market. They are anticipated to witness the highest CAGR of 14.59% during the forecast period. The growth of this segment can be attributed to the affordability and convenience of treatment plans offered. Several vendors now offer body contouring devices for skin tightening, skin rejuvenation, and fat reduction products online at affordable costs, enabling individuals to safely use them without professional instructions or consultations.

North America has the highest market share in the global body contouring devices market due to factors such as the growing demand for a youthful appearance, a rising obese population, and high healthcare spending. The United States, in particular, has the highest healthcare spending for medical aesthetic procedures and ranks first in both surgical and non-surgical aesthetic procedures as of 2020. Additionally, the country has a substantial number of plastic surgeons (7,000) according to an ISAPS report.

In Europe, the increasing demand for cosmetic surgeries is driven by the adoption of energy-based and laser devices for skin tightening and body contouring, which provide better results in the market. Body contouring treatments are popular in Europe, supported by factors such as the growing obese population, rising awareness, advanced medical aesthetics market, and increased adoption of body contouring devices. The desire for an enhanced, youthful physical appearance also contributes to the demand for body contouring devices.

APAC accounts for a market share of 24.11% in the global body contouring devices market and is expected to witness the highest CAGR growth of 15.18% during the forecast period. The region’s market growth is fueled by the increasing obese population, growing awareness, demand for advanced medical aesthetics, and greater adoption of body contouring devices. China dominates the body contouring devices market in the region, driven by the increasing elderly population and demand for a youthful appearance. The availability of a wide range of aesthetic procedures, improved access, and high healthcare expenditure further drive the industry’s growth.

Latin America is an emerging market for body contouring devices, with Brazil experiencing significant growth in medical aesthetic procedures in 2020. Skilled medical professionals and a large customer base contribute to the market’s expansion. The region also benefits from medical tourism from other countries, stimulating the growth of the body contouring devices market.

However, the high cost of treatments and complications associated with non-surgical body contouring devices pose challenges to the overall market growth. In addition, low-income countries may face obstacles due to the lack of technologically advanced equipment and skilled professionals capable of performing these procedures, hindering the regional market’s growth during the forecast period.

---

Competitive Landscape

---

The global market for body contouring devices is characterized by high dynamism and intense competition. It features a wide array of offerings from international, regional, and local vendors, catering to diverse applications. The majority of industry players provide a comprehensive range of minimally invasive (MI) body contouring devices. Key vendors in this market include AbbVie, Cutera, Bausch Health Companies, Hologic, and FOSUN PHARMA.

Notably, there has been a notable increase in innovations and investments aimed at developing body contouring devices, driven by the desire to enhance profitability. This trend is further evidenced by a surge in product launches in recent years. For instance, InMode introduced its Morpheus8 body multipulse burst RF vulcanization technology in 2020. This RF micro-needling device offers a minimum penetration depth of approximately 7mm. Similarly, several next-generation body contouring devices have been developed, with many more in the pipeline. BTL, for example, launched EMSCULPT NEO in October 2020. This device combines pulse technologies without overheating the magnet, thereby eliminating the risk of thermal burns. Moreover, EMSCULPT NEO is a hands-free treatment that achieves an average fat reduction of 30% and muscle volume growth of 25%.

Key companies profiled in this report include AbbVie, Cutera, Bausch Health Companies, Hologic, Shanghai Fosun Pharmaceutical, Aerolase, Asclepion Laser Technologies, Beijing ADSS Development, Biolitec, Biotec Italia, BISON MEDICAL, BRERA MEDICAL TECHNOLOGIES, BTL, Cartessa Aesthetics, Candela Medical, DELEO, Dominion Aesthetic Technologies, El.En., Erchonia, ENDYMED, F Care Systems, Fotona, GSD, InMode, LUTRONIC, Lumenis, Lynton Lasers, Leaflife Technology, Merz, MicroAire Surgical Instruments, MedArt ApS, PhotoMedex, Sofwave, Sciton, ThermiGen, Venus Concept, Wavemed.

---

Key Questions Answered

---

What is the market size of the body contouring devices industry?
The global body contouring devices market was valued at USD 5.7 billion in 2021 and is projected to reach USD 12.6 billion by 2027.

What is the growth rate of the body contouring devices market?
The global body contouring devices market is expected to grow at a compound annual growth rate (CAGR) of 13.96% from 2022 to 2027.

Who are the major players in the global body contouring devices market?
The leading companies in the global body contouring devices market include AbbVie, Cutera, Bausch Health Companies, Hologic, and Shanghai Fosun Pharmaceutical.

Which region is expected to dominate the global body contouring devices market?
North America is anticipated to hold the largest share of the global body contouring devices market, estimated to reach USD 5.24 billion by 2027. The region’s larger population of young and adult age groups greatly contributes to the market’s growth.

What are the driving factors behind the growth of the body contouring devices market?
The key factors driving the global body contouring devices market include technological advancements in the field, an increasing interest from males in body contouring procedures, and a growing focus on developing muscle-building and toning devices.